Minnesota HF 4349: Provisions governing hospital reimbursement for biological products to treat rare diseases modified.

Status: Introduction and first reading, referred to Health Finance and Policy (as of 2026-03-16)

State: Minnesota · Session: 2025-2026 · Bill: HF 4349

Subjects: Health and Health Department, Hospitals and Health Facilities

Sponsors: Bierman, Bahner, Huot, Mahamoud, Reyer

View Minnesota HF 4349 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.